Skip to main content
. 2022 Nov 30;379:e073070. doi: 10.1136/bmj-2022-073070

Fig 4.

Fig 4

Vaccine effectiveness (with 95% confidence interval) of two dose schemes against SARS-CoV-2 infection, by age group, study period, and days since second dose